Kobayashi Pharmaceutical Co Ltd
TSE:4967

Watchlist Manager
Kobayashi Pharmaceutical Co Ltd Logo
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Watchlist
Price: 5 994 JPY 0.54% Market Closed
Market Cap: 445.6B JPY
Have any thoughts about
Kobayashi Pharmaceutical Co Ltd?
Write Note
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Cash Flow Statement

16.6B
-9%
Operating Cash Flow
Growth Rates:
1 Year
-18%
3 Years
-24%
5 Years
-20%
7 Years
-34%
10 Years
-
-26.4B
-35%
Investing Cash Flow
Growth Rates:
1 Year
-22%
3 Years
-203%
5 Years
-496%
7 Years
-
10 Years
-
-19.8B
-2%
Financing Cash Flow
Growth Rates:
1 Year
-16%
3 Years
-218%
5 Years
-46%
7 Years
-5%
10 Years
-

Cash Flow Statement
Kobayashi Pharmaceutical Co Ltd

Rotate your device to view
Cash Flow Statement
Currency: JPY
Jun-2005 Dec-2005 Jun-2006 Dec-2006 Jun-2007 Dec-2007 Jun-2008 Dec-2008 Jun-2009 Dec-2009 Jun-2010 Sep-2010 Dec-2010 Mar-2011 Sep-2011 Mar-2012 Sep-2012 Mar-2013 Sep-2013 Mar-2014 Sep-2014 Mar-2015 Sep-2015 Mar-2016 Sep-2016 Dec-2016 Jun-2017 Dec-2017 Jun-2018 Dec-2018 Jun-2019 Dec-2019 Jun-2020 Dec-2020 Jun-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023 Jun-2024
Operating Cash Flow
Net Income
(29)
571
1 625
3 340
(516)
(1 712)
419
1 407
(1 660)
(1 296)
1 693
7 407
2 712
(931)
13 031
19 822
20 354
18 853
17 364
19 666
18 567
20 056
20 797
18 755
20 508
19 802
29 567
22 572
23 534
25 304
26 162
26 804
26 101
26 635
26 790
27 636
27 459
27 950
28 155
27 559
18 749
Depreciation & Amortization
39
77
(19)
(20)
119
113
94
548
(15)
45
25
1 062
(74)
1 006
3 738
3 231
3 017
2 969
3 020
3 096
3 082
3 095
3 103
3 071
3 296
2 625
4 348
3 519
3 407
3 403
3 486
4 127
4 727
4 106
4 107
4 835
5 118
5 358
5 568
6 057
7 124
Other Non-Cash Items
964
899
(2 034)
(1 882)
(536)
111
849
(1 206)
2 553
2 821
(1 660)
(1 611)
(1 827)
4 199
6 040
(386)
(3 280)
(1 750)
185
(6 509)
(5 752)
(1 486)
(1 086)
(1 088)
(719)
(763)
(632)
1 124
1 517
1 582
559
153
332
199
265
(276)
(263)
(351)
(439)
(1 052)
2 506
Cash Taxes Paid
253
208
1 024
1 430
234
323
(1 025)
(905)
1 454
(103)
(1 231)
(1 148)
(608)
(574)
5 112
4 761
6 965
7 872
7 284
7 225
6 609
6 380
5 815
6 416
5 350
3 703
6 935
6 287
7 092
7 953
7 942
7 829
8 056
7 972
8 237
8 464
8 124
8 003
8 280
8 358
7 916
Cash Interest Paid
3
0
(2)
(14)
2
(11)
3
66
1
(46)
(9)
3
(29)
(18)
41
28
28
18
1
9
15
16
20
19
12
21
28
27
21
26
26
12
22
15
12
17
20
18
20
22
28
Change in Working Capital
(334)
1 231
(444)
(4 374)
1 833
(1 183)
(2 713)
(1 328)
(2 531)
1 147
2 218
(2 195)
(1 843)
2 658
(7 131)
(5 419)
(8 836)
(10 829)
(7 598)
(2 740)
(966)
(6 220)
(7 340)
(6 409)
(5 027)
(5 567)
(7 997)
(4 864)
(8 878)
(10 283)
(9 347)
(10 996)
(6 376)
(6 956)
(9 373)
(9 776)
(871)
(1 065)
(12 942)
(14 204)
(11 743)
Cash from Operating Activities
640
N/A
2 778
+334%
(872)
N/A
(2 936)
-237%
900
N/A
(2 671)
N/A
(1 351)
+49%
(579)
+57%
(1 653)
-185%
2 717
N/A
2 276
-16%
4 663
+105%
(1 032)
N/A
6 932
N/A
15 678
+126%
17 248
+10%
11 255
-35%
9 243
-18%
12 971
+40%
13 513
+4%
14 931
+10%
15 445
+3%
15 474
+0%
14 329
-7%
18 058
+26%
16 097
-11%
25 286
+57%
22 351
-12%
19 580
-12%
20 006
+2%
20 860
+4%
20 088
-4%
24 784
+23%
23 984
-3%
21 789
-9%
22 419
+3%
31 443
+40%
31 892
+1%
20 342
-36%
18 360
-10%
16 636
-9%
Investing Cash Flow
Capital Expenditures
558
726
158
79
(597)
(873)
489
275
194
(528)
(300)
(938)
727
172
(1 958)
(2 092)
(2 324)
(2 875)
(3 355)
(3 344)
(3 520)
(3 678)
(3 749)
(4 047)
(4 495)
(3 485)
(5 186)
(3 205)
(3 545)
(3 701)
(4 126)
(4 804)
(4 653)
(4 149)
(3 787)
(4 185)
(7 601)
(16 229)
(18 912)
(13 569)
(27 460)
Other Items
633
(3 255)
2 305
(4 960)
(3 595)
6 846
1 027
7 241
812
(5 090)
(2 554)
(3 182)
(4 015)
(6 602)
(4 702)
(837)
(20 086)
(23 730)
(4 532)
(3 615)
(1 302)
(862)
(5 173)
(6 885)
(5 315)
2 966
9 480
10 244
(1 847)
(4 361)
(299)
(268)
3 744
(8 507)
(4 909)
12 176
10 669
1 917
(2 702)
(6 007)
1 088
Cash from Investing Activities
1 191
N/A
(2 529)
N/A
2 463
N/A
(4 881)
N/A
(4 192)
+14%
5 973
N/A
1 516
-75%
7 516
+396%
1 006
-87%
(5 618)
N/A
(2 854)
+49%
(4 120)
-44%
(3 288)
+20%
(6 430)
-96%
(6 660)
-4%
(2 929)
+56%
(22 410)
-665%
(26 605)
-19%
(7 887)
+70%
(6 959)
+12%
(4 822)
+31%
(4 540)
+6%
(8 922)
-97%
(10 932)
-23%
(9 810)
+10%
(519)
+95%
4 294
N/A
7 039
+64%
(5 392)
N/A
(8 062)
-50%
(4 425)
+45%
(5 072)
-15%
(909)
+82%
(12 656)
-1 292%
(8 696)
+31%
7 991
N/A
3 068
-62%
(14 312)
N/A
(21 614)
-51%
(19 576)
+9%
(26 372)
-35%
Financing Cash Flow
Net Issuance of Common Stock
7
(1 203)
(2)
1 357
13
(95)
(1 477)
(1 515)
1 468
1 469
0
0
1
1
0
(1)
(1)
(1)
(2)
(2)
(1 500)
(1 501)
1 304
(6 485)
(10 004)
(7 963)
(12 826)
(4 716)
508
361
(8 014)
(8 014)
0
0
0
(3 943)
(7 999)
(14 056)
0
(12 000)
0
Net Issuance of Debt
257
1 586
(625)
(1 932)
(1 626)
537
2 728
1 970
(424)
(217)
(1 442)
(1 664)
(1 608)
(1 771)
(711)
(492)
(431)
(371)
(333)
(285)
(182)
(115)
29
46
(60)
(41)
(70)
(103)
(102)
173
(369)
(1 232)
(764)
(5)
86
(12)
(1)
(1)
0
0
0
Cash Paid for Dividends
(499)
(499)
(196)
(196)
(498)
(1 615)
967
893
(67)
(56)
(164)
(184)
(339)
(356)
(2 702)
(2 785)
(3 194)
(3 357)
(3 357)
(3 521)
(3 522)
(3 552)
(3 664)
(3 837)
(3 892)
(3 919)
(6 053)
(4 343)
(4 577)
(4 818)
(5 214)
(5 333)
(5 697)
(5 784)
(6 017)
(6 251)
(6 464)
(6 509)
(6 885)
(7 223)
(7 583)
Other
2 650
2 703
(2 567)
(2 704)
(83)
0
0
0
0
0
0
0
0
0
0
(14)
(16)
0
1
(1)
(1)
13
90
77
0
1
2
0
0
(1)
(4)
(2)
(1)
(230)
(315)
(171)
(178)
(193)
(211)
(240)
(257)
Cash from Financing Activities
2 415
N/A
2 587
+7%
(3 390)
N/A
(3 475)
-3%
(2 194)
+37%
(1 173)
+47%
2 218
N/A
1 348
-39%
977
-28%
1 196
+22%
(1 606)
N/A
(1 848)
-15%
(1 946)
-5%
(2 126)
-9%
(3 413)
-61%
(3 292)
+4%
(3 642)
-11%
(3 729)
-2%
(3 691)
+1%
(3 809)
-3%
(5 205)
-37%
(5 155)
+1%
(2 241)
+57%
(10 199)
-355%
(13 955)
-37%
(11 922)
+15%
(18 947)
-59%
(9 162)
+52%
(4 172)
+54%
(4 285)
-3%
(13 601)
-217%
(14 581)
-7%
(6 462)
+56%
(6 019)
+7%
(6 246)
-4%
(10 377)
-66%
(14 642)
-41%
(20 759)
-42%
(17 096)
+18%
(19 463)
-14%
(19 840)
-2%
Change in Cash
Effect of Foreign Exchange Rates
14
39
(10)
(69)
(10)
(22)
(156)
(173)
301
186
(107)
(210)
(153)
(290)
(300)
(154)
(57)
578
1 056
831
124
751
1 098
(167)
(2 104)
(760)
(991)
137
(30)
(431)
(315)
(79)
(97)
(425)
370
797
1 607
673
371
890
1 163
Net Change in Cash
4 260
N/A
2 875
-33%
(1 809)
N/A
(11 361)
-528%
(5 496)
+52%
2 107
N/A
2 227
+6%
8 112
+264%
631
-92%
(1 519)
N/A
(2 291)
-51%
(1 515)
+34%
(6 419)
-324%
(1 914)
+70%
5 305
N/A
10 873
+105%
(14 854)
N/A
(20 513)
-38%
2 449
N/A
3 576
+46%
5 028
+41%
6 501
+29%
5 409
-17%
(6 969)
N/A
(7 811)
-12%
2 896
N/A
9 642
+233%
20 365
+111%
9 986
-51%
7 228
-28%
2 519
-65%
356
-86%
17 316
+4 764%
4 884
-72%
7 217
+48%
20 830
+189%
21 476
+3%
(2 506)
N/A
(17 997)
-618%
(19 789)
-10%
(28 413)
-44%
Free Cash Flow
Free Cash Flow
1 198
N/A
3 504
+192%
(714)
N/A
(2 857)
-300%
303
N/A
(3 544)
N/A
(862)
+76%
(304)
+65%
(1 459)
-380%
2 189
N/A
1 976
-10%
3 725
+89%
(305)
N/A
7 104
N/A
13 720
+93%
15 156
+10%
8 931
-41%
6 368
-29%
9 616
+51%
10 169
+6%
11 411
+12%
11 767
+3%
11 725
0%
10 282
-12%
13 563
+32%
12 612
-7%
20 100
+59%
19 146
-5%
16 035
-16%
16 305
+2%
16 734
+3%
15 284
-9%
20 131
+32%
19 835
-1%
18 002
-9%
18 234
+1%
23 842
+31%
15 663
-34%
1 430
-91%
4 791
+235%
(10 824)
N/A

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 210,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.